One cytokine induced in DCs exposed to ΔprtX was the anti-inflammatory IL-10, which has been proposed as a biological therapy for chronic irritable bowel disease (IBD), including Crohn’s disease and colitis (Li and He, 2004). The gene discussed is IL10; the disease is colitis.